NPI: 1366648040 · LA FOLLETTE, TN 37766 · Pediatric Nurse Practitioner · NPI assigned 06/21/2007
Authorized official ROSENDAHL, ANDREW controls 20+ related entities in our dataset. Read more
| Authorized Official | ROSENDAHL, ANDREW (CHIEF FINANCIAL OFFICER) |
| Parent Organization | EAST TENNESSEE CHILDREN'S HOSPITAL PRIMARY CARE CENTER INC. |
| NPI Enumeration Date | 06/21/2007 |
Other providers sharing the same authorized official: ROSENDAHL, ANDREW
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 3,633 | $149K |
| 2019 | 848 | $47K |
| 2020 | 925 | $53K |
| 2021 | 1,368 | $59K |
| 2022 | 1,397 | $88K |
| 2023 | 2,528 | $150K |
| 2024 | 3,278 | $148K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 5,198 | 4,417 | $342K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1,791 | 1,503 | $174K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 1,749 | 1,526 | $77K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 321 | 295 | $29K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 201 | 176 | $20K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 198 | 169 | $9K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 325 | 195 | $9K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 94 | 84 | $9K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 158 | 146 | $5K |
| 92551 | 496 | 403 | $5K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 233 | 207 | $4K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 324 | 262 | $4K |
| 99173 | 446 | 370 | $2K | |
| 3008F | 1,062 | 907 | $1K | |
| 96161 | 99 | 94 | $1K | |
| 96127 | 166 | 133 | $904.85 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 69 | 58 | $594.94 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 36 | 36 | $387.50 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 39 | 37 | $317.74 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 15 | 14 | $188.95 |
| 90661 | 71 | 66 | $184.25 | |
| 36416 | 71 | 63 | $70.35 | |
| 90677 | 80 | 72 | $0.00 | |
| 90680 | 66 | 64 | $0.00 | |
| 90686 | 393 | 342 | $0.00 | |
| 90723 | 68 | 66 | $0.00 | |
| 90647 | 39 | 38 | $0.00 | |
| 90674 | 12 | 12 | $0.00 | |
| 90670 | 124 | 119 | $0.00 | |
| 90685 | 33 | 33 | $0.00 |